This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
MyBioSource
product type :
antibody
product name :
MAb to CD40L
catalog :
MBS312099
quantity :
1 mg
price :
615 USD
clonality :
monoclonal
host :
mouse
conjugate :
nonconjugated
clone name :
1H4
reactivity :
human
application :
enzyme immunoassay
product information
catalog number :
MBS312099
products type :
Antibody
products full name :
MAb to CD40L
products short name :
CD40L
products name syn :
Monoclonal Antibody to Human CD40 Ligand
other names :
CD40 ligand; CD40 ligand; CD40 ligand; CD40-L; OTTHUMP00000024130; OTTHUMP00000024131; CD40 antigen ligand; T-cell antigen Gp39; T-B cell-activating molecule; TNF-related activation protein; tumor necrosis factor (ligand) superfamily member 5; CD40 ligand; T-cell antigen Gp39; TNF-related activation protein; TRAP; Tumor necrosis factor ligand superfamily member 5
other gene names :
CD40LG; CD40LG; IGM; IMD3; TRAP; gp39; CD154; CD40L; HIGM1; T-BAM; TNFSF5; hCD40L; CD40L; TNFSF5; TRAP
uniprot entry name :
CD40L_HUMAN
clonality :
Monoclonal
isotype :
IgG1
clone :
1H4
host :
Host: Mouse. Hybridization of Sp 2/0 myeloma cells with spleen cells from Balb/c mice. Source: Ascites
reactivity :
Human
sequence length :
261
specificity :
CD40L. Soluble human CD40L. Can be used for detection of human sCD40L in serum.
purity :
>90% pure. Protein A Sepharose chromatography. Purity is tested by electrophoresis.
form :
Purified, Liquid
concentration :
5.7mg/ml (Sigma protein assay kit)
storage stability :
Store at 2 to 8 degree C.
tested application :
EIA/ELISA, Immunoassay Antibody Pairs
other info1 :
Immunogen: Recombinant human soluble CD40 Ligand/TRAP Analog conjugates with BSA. Affinity Constant: Not determined
other info2 :
Buffer: PBS, pH 7.4. Preservative: 0.1% Sodium azide. Warnings: This product contains sodium azide, which has been classified as Xn (Harmful), in European Directive 67/548/EEC in the concentration range of 0.1-1.0%. When disposing of this reagent through lead or copper plumbing, flush with copious volumes of water to prevent azide build-up in drains.
products categories :
Monoclonal Antibodies to Human CDs
ncbi gi num :
4557433
ncbi acc num :
NP_000065.1
ncbi gb acc num :
NM_000074.2
uniprot acc num :
P29965
ncbi mol weight :
29,274 Da
ncbi pathways :
Adaptive Immunity Signaling Pathway (366160); Allograft Rejection Pathway (83123); Allograft Rejection Pathway (535); Asthma Pathway (83120); Asthma Pathway (532); Autoimmune Thyroid Disease Pathway (83121); Autoimmune Thyroid Disease Pathway (533); CD40/CD40L Signaling Pathway (138061); Calcineurin-regulated NFAT-dependent Transcription In Lymphocytes Pathway (137993); Calcium Signaling In The CD4+ TCR Pathway (137941)
ncbi summary :
The protein encoded by this gene is expressed on the surface of T cells. It regulates B cell function by engaging CD40 on the B cell surface. A defect in this gene results in an inability to undergo immunoglobulin class switch and is associated with hyper-IgM syndrome. [provided by RefSeq]
uniprot summary :
Function: Mediates B-cell proliferation in the absence of co-stimulus as well as IgE production in the presence of IL-4. Involved in immunoglobulin class switching. Ref.10Release of soluble CD40L from platelets is partially regulated by GP IIb/IIIa, actin polymerization, and an matrix metalloproteinases (MMP) inhibitor-sensitive pathway. Ref.10. Subunit structure: Homotrimer. Subcellular location: Cell membrane; Single-pass type II membrane protein. CD40 ligand, soluble form: Secreted. Tissue specificity: Specifically expressed on activated CD4+ T-lymphocytes. Post-translational modification: The soluble form derives from the membrane form by proteolytic processing.N-linked glycan is a mixture of high mannose and complex type. Glycan structure does not influence binding affinity to CD40.Not O-glycosylated. Ref.9. Involvement in disease: Defects in CD40LG are the cause of X-linked immunodeficiency with hyper-IgM type 1 (HIGM1) [. MIM:308230]; also known as X-linked hyper IgM syndrome (XHIM). HIGM1 is an immunoglobulin isotype switch defect characterized by elevated concentrations of serum IgM and decreased amounts of all other isotypes. Affected males present at an early age (usually within the first year of life) recurrent bacterial and opportunistic infections, including Pneumocystis carinii pneumonia and intractable diarrhea due to cryptosporidium infection. Despite substitution treatment with intravenous immunoglobulin, the overall prognosis is rather poor, with a death rate of about 10% before adolescence. Ref.3 Ref.13 Ref.14 Ref.15 Ref.16 Ref.17 Ref.18 Ref.19 Ref.20 Ref.21. Sequence similarities: Belongs to the tumor necrosis factor family.
size1 :
1 mg
price1 :
615 USD
company information
MyBioSource
P.O. Box 153308
San Diego, CA 92195-3308
sales@mybiosource.com
https://www.mybiosource.com
1-888-627-0165
headquarters: USA
MyBioSource, LLC was orginally founded in Vancouver by three enthusiastic scientists who are passionate about providing the world with the best reagents available. Together, they form a company with a big vision known as MyBioSource. MyBioSource is now located in San Diego, California, USA.

"MyBioSource's number 1 vision is to be the world's number 1 quality reagents provider."

Our goal is to provide researchers, scientists and customers alike with a one-stop-shop for all of their reagents needs, whether it is monoclonal antibody, polyclonal antibody, recombinant protein, peptide, etc...

"MyBioSource offers the best products at unbeatable prices."

Please spend a few minutes to browse our online catalogs and see the wide range of products available. We ship our products through our shipping/distribution facility in San Diego, California, USA.

Would you like to receive email and e-newsletter from MyBioSource about new products, special offers and events? Please click here to join our Mailing List!